CardioEquivalencias MX

Features CardioEquivalencias MX

The CARDIOEQUIVALENCIAS calculator is an application developed by Ferrer Internacional, S.A., whose objective is to help health professionals to know the approximate equivalent doses of some ACEIs, ARAS and statins available on the market vs.
other salts of the therapeutic group, favoring therapeutic exchange of active ingredients for the management of cardiovascular health.This application allows to know a practical approach for the change of a therapy based on multiple tablets vs the use of a polypill for cardiovascular prevention in patients with hypertension.It offers a treatment suggestion based on the recommendations of the study "A practical approach to switch from a multiple pill therapeutic strategy to a polypill-based strategy for cardiovascular prevention in patients with hypertension".
Anthony Coca.
Journal of Hypertension 2020 where it is concluded that the polypill favors adherence to treatment in patients with cardiovascular risk.Therapeutic equivalent is understood as products that have the same active ingredient as the drug or the same therapeutic fraction and, when administered, clinically have the same efficacy and safety as the drug whose efficacy and safety have been determined.
NOM-EM-003-SSA1-1998-DOF.Therapeutic exchange is understood as the substitution of a drug that is chemically different from the one prescribed, but considered therapeutically equivalent or a better therapeutic alternative, based on a previously established and accepted protocol.The CARDIOEQUIVALENCES calculator contains three buttons that allow you to: convert the dose of an ARA II to the dose of an ACE inhibitor, convert the dose of an ACE inhibitor to the dose of another ACE inhibitor, and find the equivalences of lipid-lowering efficacy between the different statins, to the same reduction in the level of LDL cholesterol.Through the application of several algorithms and tables, the CARDIOEQUIVALENCES calculator shows the equivalent effective daily doses of different ACE inhibitors, ARBs and statins vs ramipril and atorvastatin to facilitate the change of therapy based on the initial values ​​of blood pressure and LDL cholesterol to achieve control adequate blood pressure and lipids for each type of patient.Due to its design, the application is very intuitive and easy to use.
Access is limited to health professionals, and both access to download the application and the access code will be provided only through the sales force to your doctors.
The code is TRIN.